HR-LCMS/MS-Based Discovery of Plant-Derived Autophagy Inducers: Astragalus dasyanthus as a New Glabrol Source

Study Background and Research Question

Autophagy is a fundamental cellular process that degrades and recycles damaged organelles and proteins, playing a crucial role in maintaining cellular homeostasis. Dysregulation of autophagy is implicated in various age-related diseases, including neurodegeneration, diabetes, and atherosclerosis. While plant extracts have long been used in traditional medicine for their health benefits, the specific bioactive compounds responsible for their effects, especially those modulating autophagy, remain incompletely characterized. Given the complexity of plant metabolomes and the variability introduced by factors such as plant part, growth stage, and region, there is a pressing need for rapid, sensitive, and high-throughput methods to pinpoint autophagy-inducing metabolites within complex mixtures. The reference study set out to address this challenge by developing and validating an HR-LCMS/MS-based dereplication workflow to identify principal autophagy activators from medicinal plant extracts.

Key Innovation from the Reference Study

The principal innovation of this research lies in its application of a high-resolution liquid chromatography–mass spectrometry/mass spectrometry (HR-LCMS/MS)-driven dereplication approach, tightly integrated with bioactivity-guided fractionation. This streamlined methodology accelerates the identification of major autophagy-inducing compounds directly from multi-component plant extracts, circumventing the need for laborious isolation and structure elucidation of every constituent. Notably, the workflow enabled the discovery of Astragalus dasyanthus as a previously unrecognized natural source of glabrol, a flavonoid with significant autophagy-modulating potential. The combination of chemical profiling and functional autophagy assays represents a methodological advance for natural product research targeting cellular quality control pathways.

Methods and Experimental Design Insights

The study employed a multi-step experimental design:

• Extraction: Ethanolic extracts were prepared from five medicinal plants, each selected for its reported or putative autophagy-enhancing properties.
• Cellular Model: The human neuroblastoma SH-SY5Y cell line was chosen due to its widespread use in autophagy and neuroprotection research.
• Bioactivity Screening: Extracts were screened for autophagy activation using Western blot detection of LC3 I/II, a standard marker for autophagosome formation.
• Fractionation and Dereplication: Active extracts underwent HPLC fractionation, and the resulting fractions were assayed for autophagy-inducing activity. HR-LCMS/MS analysis facilitated the dereplication process to rapidly assign molecular identities to bioactive fractions, focusing on known autophagy inducers where possible.

This integrated strategy allowed for the direct coupling of functional data with metabolite identification, minimizing false positives and expediting the annotation of bioactive compounds.

Core Findings and Why They Matter

The application of this HR-LCMS/MS-based workflow yielded several key outcomes:

• Validation of Workflow: The method reliably identified known autophagy inducers from established plant sources, confirming its utility for dereplication in a complex matrix.
• Discovery of Glabrol in Astragalus dasyanthus: For the first time, Astragalus dasyanthus was shown to produce glabrol, a flavonoid previously associated with autophagy induction. This expands the repertoire of botanicals available for functional autophagy studies and potentially for drug development targeting metabolic and neurodegenerative disorders.
• High-Throughput Potential: The streamlined nature of the workflow supports its application to larger natural product libraries, increasing the pace of discovery for novel autophagy inducers.

Given the interconnection between autophagy, mitochondrial function, and cellular stress responses, these findings are particularly relevant for research areas such as mitochondrial biology, metabolic regulation studies, and the development of interventions targeting age-related diseases.

Comparison with Existing Internal Articles

Internal resources such as the FCCP guide and analyses of mitochondrial uncouplers focus on mechanistic dissection of mitochondrial pathways, including the use of FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) as a gold-standard tool for disrupting oxidative phosphorylation and modulating hypoxia-inducible factor (HIF) signaling. While these articles emphasize pharmacological approaches to studying mitochondrial dynamics and cellular metabolism, the reference study demonstrates that plant-derived small molecules—such as glabrol—can also modulate autophagy, and likely intersect with mitochondrial quality control mechanisms such as mitophagy. The dereplication workflow described thus complements established chemical biology toolkits by enabling rapid identification of natural product leads for autophagy and metabolic regulation research.

Limitations and Transferability

Despite its strengths, the described workflow has several limitations. The specificity and sensitivity of autophagy induction were only assessed using the LC3 I/II Western blot in a single neuronal cell line; further validation in additional cell types and with orthogonal markers (e.g., autophagic flux assays) would strengthen the findings. Additionally, the dereplication process, while accelerated by HR-LCMS/MS, is inherently dependent on the quality of reference mass spectral libraries and may overlook entirely novel compounds. The translation of in vitro activity to in vivo efficacy or therapeutic potential remains to be established. Nonetheless, the workflow is broadly transferable to other plant and microbial extracts, and adaptable for high-throughput functional screening pipelines.

Protocol Parameters

• Plant extraction: Ethanol extraction from dried plant material; typically 1 g plant to 10 mL ethanol, room temperature overnight.
• Cell line for screening: SH-SY5Y neuroblastoma cells; seed at 1 × 10⁵ cells/well in 12-well plates.
• Autophagy assay: Treat cells with 10–100 μg/mL plant extract or HPLC fraction for 24 hours; assess LC3 I/II by Western blot.
• Fractionation: HPLC fractionation with subsequent HR-LCMS/MS analysis; collect fractions every 2 min for bioactivity testing.
• Dereplication: Compare MS/MS spectra of active fractions to reference libraries for compound identification.
• For studies requiring direct manipulation of mitochondrial function or HIF pathway inhibition, literature suggests use of FCCP at 10 μM for 24 h in prostate cancer cell lines PC-3 and DU-145 (see product information).

Research Support Resources

Researchers aiming to further dissect the interplay between autophagy, mitochondrial function, and metabolic regulation can supplement natural product screening with established tool compounds. FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) (SKU B5004) is a widely used lipophilic mitochondrial uncoupler for oxidative phosphorylation disruption, enabling detailed investigation of mitochondrial dynamics, inhibition of hypoxia-inducible factor (HIF) pathways, and downstream metabolic responses. APExBIO provides validated FCCP for experimental applications in cell-based and animal models, supporting workflows that complement the dereplication and screening approaches described above.